From “science of life”, Ayurved becomes a “slice of life” with a global market of more than 20 billion dollars

The ever-growing importance of Ayurveda has placed it at the center of the lives of millions of people in India and across the world. Created over 5000 years ago, it is considered by many to be the oldest method of healing based on the science of life. She is also referred to as the mother of all kinds of healing, who gave new life to people when there was hardly any healing system. Ayurveda finds its imprint in the ancient Vedic culture and has been taught for thousands of years by accomplished masters in an oral, practical and experiential tradition.

Globalization of Ayurveda

Due to its increasing popularity among all groups of people around the world, the globalization of Ayurvedic practices has gained momentum over the past two decades. Ayurvedic medicines are used as dietary supplements in the United States, European Union and Japan. Many doctors practice Ayurveda in many parts of the world. Installations are available in countries such as the United States, Argentina, Australia, Brazil, New Zealand, South Africa, Czech Republic, Greece, Italy, Hungary, Netherlands, Russia, United Kingdom, Israel, Japan, Nepal, Sri Lanka (Kurup, 2004) to transmit short and long term training in Ayurveda.

MoU with 25 countries

The Ayush Ministry has signed 25 country-to-country MoUs for cooperation in the field of traditional medicine and homeopathy with foreign countries. 32 MoUs have been signed with international institutes to undertake research/academic collaboration. 14 memorandums of understanding have been signed with international institutes for the creation of AYUSH academic chairs in foreign countries. The Ministry of Ayush has supported the establishment of 38 Ayush information cells in 34 foreign countries.

Relevant Rules for Manufacturing Ayurvedic Medicines

Seeing millions of people adopting Ayurveda, the Ministry of Ayush placed the manufacture of these drugs within the scope of the Medicines and Cosmetics Act 1940 and relevant rules were also established under of it. In accordance with the provisions of the Medicines Rules 1945, the manufacturing license is only granted by the competent authority of the State concerned only after ensuring that the requirements specified in Schedule T for Ayurveda medicines, Siddha, Unani and Schedule M1 for homeopathic medicines.

Pharmaco-vigilance of Ayurveda

The Ministry of Ayush has also established a central Sector Pharmacovigilance Program for Ayurvedic, Siddha Unani and Homeopathic Medicines since June 2018 to inculcate the culture of reporting, documentation and analysis of adverse drug events ( ADE) for further regulatory action. The system has a network established at three levels. All India Institute of Ayurveda (AIIA), New Delhi has been designated as the National Pharmacovigilance Coordinating Center (NPvCC). There are currently five Intermediate Pharmacovigilance Centers (IPvC) and 74 Peripheral Pharmacovigilance Centers (PPvC).

International standards are maintained

International standards for AYUSH products are governed by WHO-GMP, EU-GMP or any other standards established by importing countries and to comply with other requirements of importing countries. The WHO Certification Scheme, which is a Certificate of Pharmaceutical Product (COPP) scheme, is issued by the National Regulatory Authority (NRA) for the purposes of international trade for the registration of products in foreign countries. The Central Drug Standards Control Organization (CDSCO) issues a Certification of Pharmaceutical Product (COPP) to Ayurvedic, Siddha or Unani products after reviewing such applications in consultation with the Ministry of Ayush.

Promotion of Ayush products for Covid-19

The Ministry of Ayush has issued instructions to all State/UT Governments to authorize the issuance of a license to Ayurvedic drug manufacturers to manufacture and sell under the generic name “AyushKwath” in accordance with the provisions of the Rules on Ayush medicines and cosmetics of 1945 in the wake of the COVID-19 outbreak. During the second wave of this pandemic, scientists from reputable research institutions across the country found that AYUSH 64, a herbal formulation developed by the Central Council for Ayurvedic Science Research (CCRAS) is helpful in the treatment of asymptomatic, mild illness and moderate COVID-19 infection as an adjunct to standard care. In order to get the most out of the Ayush medicine systems, a nationwide campaign to distribute AYUSH-64 and KabasuraKudineer (Siddha Medicine) was launched across the country.

Using different Kits

During the outbreak of COVID-19/Omicron, the Ayush Ministry has been promoting the use of Ayuraksha Kit, BalRaksha Kit and Ayur Healing Kit for mass health promotion. In this regard, all state licensing authorities have been advised that the requirement for a separate license for the manufacture of kits with the specified components of Ayuraksha Kit, BalRaksha Kit and Ayur Care Kit for manufacturers with a valid individual kit component license is not required.

Ayurvedic Drug Production Support Programs

Under the National Ayush Mission (NAM) from 2014 to 2021, in addition to other services, grants have also been provided for the strengthening of state government ASU&H pharmacies. In addition, under the medicinal plant component of NAM, financial assistance has been provided in the form of a grant to encourage farmers to cultivate medicinal plants throughout the country. At present, the Central Sector Program for Ayush Oushadhi Gunavattaevam Uttpadan Samvardhan Yojana (AOGUSY) has been implemented for the year 2021-2026. One of the components of the program is the strengthening and upgrading of Ayush pharmacies to achieve higher standards.

Mobile application ‘e-CHARAK’

In order to provide a platform for herbal medicine trade and facilitate market access, the National Herbal Medicine Board (NMPB) of the Ministry of Ayush has launched the mobile application “e-CHARAK” as well as a web portal for the promotion and marketing of medicinal plants. plants/herbs. “e-CHARAK” is a platform allowing the exchange of information between different actors, mainly farmers involved in the medicinal plant sector across the country. The “e-CHARAK” app supports different local languages ​​and also provides bi-monthly market price of 100 herbal medicines from 25 herbal markets across India.

AYUSH Export Promotion Council

“AYUSH Export Promotion Council” was registered under Section 8(4) of the Companies Act 2013 on 4.01.2022 under the Ministry of Ayush in support of the Ministry of Commercial Affairs to overcome the barriers to registration of Ayush products abroad, engaging in market research and research activities abroad Ministry of Ayush under its international scholarship program offering scholarships to foreign nationals to attend Ayush courses in leading institutions in India. MoUs have been signed with London School of Hygiene & Tropical Medicine (LSH&TM), UK and Frankfurter Innovations zentrum Biotechnologie GmbH (FIZ), Frankfurt Germany for clinical research studies on Covid-19 mitigation by Ayurveda.

Ayush Market Size is Growing Rapidly

Supported by growing global and domestic demand and made possible by strong support of regulatory mechanism, research and development and backbone infrastructure by the ministry, the market size of Ayush grew by 17% in 2014-2020 to reach 18.1 US dollars. billion. According to the Research and Information System for Developing Countries (RIS) report, despite a decline in economic activity in 2020 due to the pandemic, the industry is expected to reach US$20.6 billion in 2021. and US$23.3 billion in 2022.


Comments are closed.